Bioventus Stock Probability of Future Stock Price Finishing Over 10.89
| BVS Stock | USD 4.31 0.02 0.47% |
Closest to current price Bioventus long CALL Option Payoff at Expiration
Bioventus |
Bioventus Target Price Odds to finish over 10.89
The tendency of Bioventus Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 10.89 or more in 90 days |
| 4.31 | 90 days | 10.89 | close to zero percent |
Based on a normal probability distribution, the odds of Bioventus to move over $ 10.89 or more in 90 days from now is close to zero percent (This Bioventus probability density function shows the probability of Bioventus Stock to fall within a particular range of prices over 90 days) . Probability of Bioventus price to stay between its current price of $ 4.31 and $ 10.89 at the end of the 90-day period is about 92.23 .
Considering the 90-day investment horizon the stock has the beta coefficient of 2.26 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Bioventus will likely underperform. Additionally Bioventus has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Bioventus Price Density |
| Price |
Predictive Modules for Bioventus
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bioventus. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bioventus' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bioventus Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bioventus is not an exception. The market had few large corrections towards the Bioventus' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bioventus, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bioventus within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.29 | |
β | Beta against NYSE Composite | 2.26 | |
σ | Overall volatility | 0.38 | |
Ir | Information ratio | -0.05 |
Bioventus Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bioventus for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bioventus can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bioventus had very high historical volatility over the last 90 days | |
| Bioventus has high likelihood to experience some financial distress in the next 2 years | |
| The company has 409.48 M in debt with debt to equity (D/E) ratio of 1.17, which is OK given its current industry classification. Bioventus has a current ratio of 0.92, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist Bioventus until it has trouble settling it off, either with new capital or with free cash flow. So, Bioventus' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioventus sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioventus to invest in growth at high rates of return. When we think about Bioventus' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the last year's revenue of 512.35 M. Reported Net Loss for the year was (96.74 M) with profit before taxes, overhead, and interest of 302.71 M. | |
| About 66.0% of Bioventus shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Is Bravura Solutions Limited Trading At A 33 percent Discount |
Bioventus Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bioventus Stock often depends not only on the future outlook of the current and potential Bioventus' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bioventus' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 62.6 M | |
| Cash And Short Term Investments | 37 M |
Bioventus Technical Analysis
Bioventus' future price can be derived by breaking down and analyzing its technical indicators over time. Bioventus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bioventus. In general, you should focus on analyzing Bioventus Stock price patterns and their correlations with different microeconomic environments and drivers.
Bioventus Predictive Forecast Models
Bioventus' time-series forecasting models is one of many Bioventus' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Bioventus' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Bioventus
Checking the ongoing alerts about Bioventus for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bioventus help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Bioventus had very high historical volatility over the last 90 days | |
| Bioventus has high likelihood to experience some financial distress in the next 2 years | |
| The company has 409.48 M in debt with debt to equity (D/E) ratio of 1.17, which is OK given its current industry classification. Bioventus has a current ratio of 0.92, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist Bioventus until it has trouble settling it off, either with new capital or with free cash flow. So, Bioventus' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioventus sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioventus to invest in growth at high rates of return. When we think about Bioventus' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the last year's revenue of 512.35 M. Reported Net Loss for the year was (96.74 M) with profit before taxes, overhead, and interest of 302.71 M. | |
| About 66.0% of Bioventus shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Is Bravura Solutions Limited Trading At A 33 percent Discount |
Check out Bioventus Backtesting, Bioventus Valuation, Bioventus Correlation, Bioventus Hype Analysis, Bioventus Volatility, Bioventus History as well as Bioventus Performance. For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Bioventus Stock analysis
When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Bioventus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioventus. If investors know Bioventus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioventus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.54) | Revenue Per Share 8.178 | Quarterly Revenue Growth 0.076 | Return On Assets 0.0012 | Return On Equity (0.38) |
The market value of Bioventus is measured differently than its book value, which is the value of Bioventus that is recorded on the company's balance sheet. Investors also form their own opinion of Bioventus' value that differs from its market value or its book value, called intrinsic value, which is Bioventus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioventus' market value can be influenced by many factors that don't directly affect Bioventus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioventus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioventus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioventus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.